SANOFI

NASDAQ

SNY

lauralea

No rising wedges noted and is close to B/O (breakout) Stop can be below handle low or melow mid cup Everyone has a different tolerance on stops. I think it is imperative to have a goal in mind before you place a trade. I am working on trying to focus on just a few trades at a time as I have an issue with wanting to buy everything! LOL I end up with smaller...

SonalSignals2018

PRNB,SNY: Sanofi 2020-08-17 01:00:00 Sanofi to acquire Principia Biopharma

dread003111

On news about USA addiction from Chinese factories. www.wsj.com

Godbe

very nice upward triangle, near the apex. Almost break the upper resistance level. Keep an eye out. Green is profit taking areas, red is stop lost.

StockAnalystPro

NASDAQ:SNY is showing signs that it is heading up to around the 54.5 area .There is a possibility that It could return back to around the 48 area and then bounce back from there to around the 54.5 area but I think price would rather break significantly above the 50 until around the 54-55 area .

SpHiinX-BD

Bullish Momentum BUY

BOS_Trader

Looking for next leg in channel to fill gap and more news surrounding the COVID-19 Drug by Sanofi - With Pumper Trump having holdings here. I see this moving to target www.marketwatch.com

UnknownUnicorn6877177

Best Penny Stocks to buy and watch in April 2020 : SNY 😊Please LIKE & FOLLOW for more VIP Hunters signals in Forex , penny stocks and cryptocurrency Date of the Release : SNY FDA date of approval - 25th of April What’s the real story : The beauty of Penny stock that I trade in particular , They are ALL pharmaceutical companies. The AMAZING part is 90% of...

Sergio_Security

Sanofi produces Plaquenil, and Quinoric (en.wikipedia.org) "On 16 March 2020, advisor to the French Government on COVID-19, Professor Didier Raoult, announced that a non-randomized unblinded trial involving 24 people from the south east of France supported the claim that hydroxychloroquine was an effective treatment...

Bixley

SNY has experience two bump and runs throughout the course of its listing. Will a third follow? If so will it be immediately or will further trend strengthening occur. The bump and runs also resulted in two triple tops.

RocketTickers

REGN,SNY: Sanofi 2019-03-11 15:45:00 FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents - PR Newswire

frunch_rosco123

SNI trading in between the 20 and 50 SMA on monthly chart and slightly below the 50 SMA on the daily chart. Also trading slightly below the 200 SMA on the hourly chart. I've never traded this stock before so will stay neutral on this one. Trade with confidence.